Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Validity of the Central Sensitization Inventory compared with traditional measures of disease severity in fibromyalgia.

< BACK TO ARCHIVE


Papers: 10 Sep 2022 - 16 Sep 2022

RESEARCH TYPE:
Psychology


Human Studies


2022 Sep 13


Pain Pract


http://www.ncbi.nlm.nih.gov/pubmed/36097821?dopt=Abstract

Validity of the Central Sensitization Inventory compared with traditional measures of disease severity in fibromyalgia.

Authors

Validity of the Central Sensitization Inventory compared with traditional measures of disease severity in fibromyalgia.
Salaffi F, Farah S, Mariani C, Sarzi-Puttini P, Di Carlo M
Pain Pract. 2022 Sep 13.
PMID: 36097821.

Abstract

The goal of the present study was to explore additional evidence of convergent and discriminant validity of the Central Sensitization Inventory (CSI) in a large sample of subjects with fibromyalgia (FM).
Read This Paper